We have previously shown the regulatory effects of several microRNA (miRNA) species on AD-associated gene products, including miR-101 and miR-153, which act on the APP 3'-UTR [21, 22], and miR-339-5p on the 3'-UTR of the BACE1 transcript [23]. This evidence concerns the gene APP and Alzheimer disease.